David L. Grange
Director · Tonix Pharmaceuticals Holding Corp.
Individual
- 2025
- May 14, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David L. Grange files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Seth Lederman - $373K in TNXP purchases and sales in the last 12 months
- Richard Newcomb Stillwell - $58K in TNXP purchases and sales in the last 12 months
- Carolyn E. Taylor - $15K in TNXP purchases and sales in the last 12 months
- Richard H. Bagger - $13K in TNXP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David L. Grange?
David L. Grange is a corporate insider, tracked as Director of Tonix Pharmaceuticals Holding Corp. (TNXP). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did David L. Grange last file a Form 4?
The most recent primary Form 4 on record is dated 14 May 2026, one of 2 filings going back to 2025.